174 related articles for article (PubMed ID: 35514369)
1. Improved therapeutic efficacy of quercetin-loaded polymeric nanoparticles on triple-negative breast cancer by inhibiting uPA.
Zhou Y; Chen D; Xue G; Yu S; Yuan C; Huang M; Jiang L
RSC Adv; 2020 Sep; 10(57):34517-34526. PubMed ID: 35514369
[TBL] [Abstract][Full Text] [Related]
2. Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase-Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy.
Zhou Y; Yu S; Chen D; Li H; Xu P; Yuan C; Jiang L; Huang M
Mol Pharm; 2023 Feb; 20(2):905-917. PubMed ID: 36463525
[TBL] [Abstract][Full Text] [Related]
3. Quercetin Has Antimetastatic Effects on Gastric Cancer Cells via the Interruption of uPA/uPAR Function by Modulating NF-κb, PKC-δ, ERK1/2, and AMPKα.
Li H; Chen C
Integr Cancer Ther; 2018 Jun; 17(2):511-523. PubMed ID: 28627240
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth and lung metastasis of breast cancer by tumor-homing triple-bioresponsive nanotherapeutics.
Zhang X; Huang Y; Song H; Canup BSB; Gou S; She Z; Dai F; Ke B; Xiao B
J Control Release; 2020 Dec; 328():454-469. PubMed ID: 32890553
[TBL] [Abstract][Full Text] [Related]
5. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy.
He X; Zhang J; Li C; Zhang Y; Lu Y; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Guo Q; Sun T; Cheng J; Jiang C
Theranostics; 2018; 8(18):4884-4897. PubMed ID: 30429875
[TBL] [Abstract][Full Text] [Related]
6. Delivery of novel coumarin-dihydropyrimidinone conjugates through mixed polymeric nanoparticles to potentiate therapeutic efficacy against triple-negative breast cancer.
Ghosh A; Upadhyay P; Sarker S; Das S; Bhattacharjee M; Bhattacharya S; Ahir M; Guria S; Gupta P; Chattopadhyay S; Ghosh S; Adhikari S; Adhikary A
Biomater Sci; 2021 Aug; 9(16):5665-5690. PubMed ID: 34259681
[TBL] [Abstract][Full Text] [Related]
7. Methoxy poly(ethylene glycol)-poly(lactide) nanoparticles encapsulating quercetin act as an effective anticancer agent by inducing apoptosis in breast cancer.
Sharma G; Park J; Sharma AR; Jung JS; Kim H; Chakraborty C; Song DK; Lee SS; Nam JS
Pharm Res; 2015 Feb; 32(2):723-35. PubMed ID: 25186442
[TBL] [Abstract][Full Text] [Related]
8. Self-assembly of Hyaluronic Acid-Cu-Quercetin flavonoid nanoparticles: synergistic chemotherapy to target tumors.
Yue H; Zhao X; Yong Q; Shi M; Jiang X; Zhang Y; Yu X
PeerJ; 2023; 11():e15942. PubMed ID: 37663303
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting the proliferation, migration and invasion of triple negative breast cancer cells through anti-tumor human serum albumin nanoparticles loading aziditaxel as a novel taxane derivative.
Chen LQ; Zhang ZM; Huang W; Gao ZG; Fang WS; Jin MJ; Yu L
Pharmazie; 2017 Mar; 72(3):152-160. PubMed ID: 29442050
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells.
Meng D; Lei M; Han Y; Zhao D; Zhang X; Yang Y; Liu R
Onco Targets Ther; 2018; 11():7733-7743. PubMed ID: 30464522
[TBL] [Abstract][Full Text] [Related]
11. Enhancing the anti-colon cancer activity of quercetin by self-assembled micelles.
Xu G; Shi H; Ren L; Gou H; Gong D; Gao X; Huang N
Int J Nanomedicine; 2015; 10():2051-63. PubMed ID: 25844036
[TBL] [Abstract][Full Text] [Related]
12. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
13. Application of Nanoparticles for Efficient Delivery of Quercetin in Cancer Cells.
Homayoonfal M; Aminianfar A; Asemi Z; Yousefi B
Curr Med Chem; 2024; 31(9):1107-1141. PubMed ID: 36856173
[TBL] [Abstract][Full Text] [Related]
14. Polyethyleneimine- -Tocopherol Hydrogen Succinate/Hyaluronic Acid-Quercetin (PEI-TOS/HA-QU) Core-Shell Micelles Delivering Paclitaxel for Combinatorial Treatment of MDR Breast Cancer.
Qian J; Liu S; Yang T; Xiao Y; Sun J; Zhao J; Zhang Z; Xie Y
J Biomed Nanotechnol; 2021 Mar; 17(3):382-398. PubMed ID: 33875073
[TBL] [Abstract][Full Text] [Related]
15. Orally Administered Halofuginone-Loaded TPGS Polymeric Micelles Against Triple-Negative Breast Cancer: Enhanced Absorption and Efficacy with Reduced Toxicity and Metastasis.
Zuo R; Zhang Y; Chen X; Hu S; Song X; Gao X; Gong J; Ji H; Yang F; Peng L; Fang K; Lv Y; Zhang J; Jiang S; Guo D
Int J Nanomedicine; 2022; 17():2475-2491. PubMed ID: 35668999
[TBL] [Abstract][Full Text] [Related]
16. A curcumin analog CA-5f inhibits urokinase-type plasminogen activator and invasive phenotype of triple-negative breast cancer cells.
Kim M; Moon A
Toxicol Res; 2022 Jan; 38(1):19-26. PubMed ID: 35070937
[TBL] [Abstract][Full Text] [Related]
17. uPAR enhances malignant potential of triple-negative breast cancer by directly interacting with uPA and IGF1R.
Huber MC; Mall R; Braselmann H; Feuchtinger A; Molatore S; Lindner K; Walch A; Gross E; Schmitt M; Falkenberg N; Aubele M
BMC Cancer; 2016 Aug; 16():615. PubMed ID: 27502396
[TBL] [Abstract][Full Text] [Related]
18. Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway.
Li J; Zhang J; Wang Y; Liang X; Wusiman Z; Yin Y; Shen Q
Int J Pharm; 2017 May; 523(1):300-309. PubMed ID: 28336457
[TBL] [Abstract][Full Text] [Related]
19. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).
Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J
Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520
[TBL] [Abstract][Full Text] [Related]
20. Antimetastatic Potential of Quercetin Analogues with Improved Pharmacokinetic Profile: A Pharmacoinformatic Preliminary Study.
Pavlović N; Milošević N; Đjanić M; Goločorbin-Kon S; Stanimirov B; Stankov K; Mikov M
Anticancer Agents Med Chem; 2022; 22(7):1407-1413. PubMed ID: 34102994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
